An enzyme-linked immunosorbent assay for detecting human immunoglobulin G to spotted fever group rickettsiae was developed and tested. The assay uses proteinase K-resistant material, characteristic of the rickettsial lipopolysaccharides shown to be group specific by immunoblots, as the antigen. The results indicate that the assay provides a sensitive, yet specific, alternative method for diagnosing rickettsial diseases.
The immunofluorescent-antibody (IFA) test is widely used for detecting antibodies to spotted fever group (SFG) rickettsial diseases. Although reliable, this method is timeconsuming, and the results are subject to interpretation. To develop an alternate test, we used an enzyme-linked immunosorbent assay (ELISA) because it was faster, less complicated, and more objective than the IFA. The ELISA, unlike the IFA, can also be automated. In our hands, whole solubilized SFG rickettsiae used as the plate-coating antigen in an ELISA cross-reacted to a high degree with sera from patients diagnosed (by IFA) with typhus group (TG) rickettsial infections. This cross-reaction was also seen in the IFA occasionally, but the homologous titer was higher than the heterologous titer, so both antigen groups were tested concurrently to determine the group antigen. Similar crossreactivity was seen in ELISAs with sera from patients diagnosed with other bacterial and rickettsial diseases using the whole solubilized rickettsial antigen. Thus, an alternative to whole solubilized rickettsiae was needed as an ELISA antigen.
Previous studies with guinea pig sera indicated that group cross-reactivity could be eliminated by removing the rickettsial proteins and using the remaining lipopolysaccharide (LPS) as the antigen (11). Anacker et al. reported monoclonal antibodies reactive with SFG rickettsial LPS that are group specific (1). Furthermore, rabbit antibodies raised to the erythrocyte-sensitizing substance, an LPS-like product obtained from Rickettsia rickettsii after boiling the rickettsiae in 0.1 N sodium hydroxide, were shown to be group specific (4), suggesting that the rickettsial LPS may be a specific ELISA antigen. Thus, the human immunoglobulin G (IgG) response to rickettsial LPS may also be group specific.
Rickettsia australis NQTT was grown in Vero E-6 cells with minimal essential medium supplemented with L-glutamine and 2% fetal calf serum. R. australis was chosen as the model SFG rickettsia because sera used in preliminary studies were from Australia and the proteinase K-treated material has a banding pattern identical to that ofR rickettsii by Western blot (immunoblot) (Fig. 1) . The rickettsiae were * Corresponding author. cultivated at 33°C, and the growth was monitored by Gimenez stain (3) . When 90% of the cells were infected, the rickettsiae were harvested. The cell suspensions were made noninfectious by adding 0.1% Formalin and storing at 4°C overnight. Rickettsiae were purified from host cell debris by Renografin density centrifugation as described previously (12) . After a Gimenez stain determined that the suspension was free of host cell contaminants, a Lowry protein assay (6) was performed to determine protein concentration.
To prepare the crude LPS, 150 ,ul of phosphate-buffered saline (PBS; pH 7.2), 20 ,u of 10% sodium dodecyl sulfate, and 24 ,ul of proteinase K (10 ,g/,u) were added to 50 ,ul of purified rickettsiae (8 ,ug of protein per ,ul). The mixture was incubated at 56°C for 90 min and then heated to 95°C for 5 min to inactivate the proteinase K. A small aliquot of the LPS solution was electrophoresed through a 15% gel, and a modified silver stain (5) demonstrated the ladder-like pattern of banding that is characteristic of LPS (Fig. 2) . While the ladder-like pattern of bands suggests LPS, small proteinase K-resistant proteins probably account for a few bands. For the LPS-ELISA, the crude LPS solution was diluted to 1 ml in carbonate buffer, pH 9.6.
The sera used for immunoblots and for LPS-ELISA were reference diagnostic specimens submitted to the Centers for Disease Control (CDC) to determine their IFA titers to three rickettsial agents: SFG (R. rickettsii) or TG (Rickettsia typhi) rickettsiae and Ehrlichia canis. The IFA procedures were performed by methods described previously (8) .
Immunoblots were performed by the method of Towbin et al. (10) , using an IgG-specific anti-human serum conjugated with peroxidase (Bio-Rad Laboratories, Richmond, Va.). Samples were either whole solubilized R. australis or crude LPS prepared as described above. Immunoblot strips of whole solubilized rickettsiae were reacted with human sera having both positive and negative IFA titers to various rickettsiae (Fig. 3A) for SFG rickettsiae were positive by the LPS-ELISA. None of the other agents tested was positive for SFG rickettsiae by the LPS-ELISA. All sera that were positive exclusively for SFG rickettsiae by IFA were also positive by the LPS-ELISA. Six samples from patients with diagnostic IFA titers to SFG and TG rickettsiae were tested with the LPS-ELISA.
Five of these six samples were also positive by the SFG rickettsia LPS-ELISA. The patients exhibiting titers to both the SFG and TG rickettsiae were included in this study to better understand the humoral immune response to these agents. Since the human sera used in the test were sent to the CDC to confirm a possible rickettsial infection, and no serum sample was taken before a possible infection, the past exposure of the patients whose sera were used is not known. (9) . However, this cross-reactivity was not seen when an IgG-specific conjugate was used in the LPS-ELISA. Our results indicate that the protein antigens of SFG rickettsiae are the source of cross-reactivity observed on the immunoblots and occasionally by IFA.
The SFG rickettsia LPS-ELISA is better suited for largescale epidemiologic investigations than are other tests. The speed and simplicity of the ELISA are advantages over the indirect hemagglutination and complement fixation tests. Moreover, lack of cross-reactivity with the LPS-ELISA is (2) . However, the LPS-ELISA is not without drawbacks. Both the IFA and the ELISA have limitations in diagnosis of SFG rickettsial diseases because the earliest that IgG seroconversion has been seen after the onset of illness is 6 days (7). While this delay is a problem for laboratory confirmation of clinical diagnosis, it is not a problem for epidemiologic investigations.
